Founder Kathryn Cross wrote that she sold Anja Health; the post says service continuity would remain uninterrupted and the team would continue with the buyer.
SourceCord Blood Banking Reimagined
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Anja Health is a Los Angeles-based newborn stem cell banking company focused on making cord blood, cord tissue, and placenta preservation more accessible and affordable for expectant parents; public updates in 2026 indicate founder Kathryn Cross sold the company and Jan Chen became CEO.
Primary product
Newborn stem cell banking kits and long-term cryostorage for cord blood, cord tissue, and placenta
Founded
2021
Headquarters
Los Angeles, California, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Cord blood, cord tissue, and placenta stem cell banking
Offices
0 jobs at Anja Health
Check back later for new openings
Business model
Stage
Seed
Total raised
$5.3M
Latest round
Seed VC · May 2022
Latest amount
$4.5M
May 2022 · Seven Seven Six
Mar 2022
Aug 2021
Leadership
Chief Executive Officer
Founder
Director of Customer Experience
Investors
Mission-driven, women-led, family-focused, and accessibility-oriented, with public messaging emphasizing warmth, education, personalized support, and consumer-friendly service.
Compensation
No broad public compensation bands were disclosed. One public contractor-style web developer posting showed roughly $30,000-$60,000 per year and remote work allowed, which is the clearest salary signal found.
Benefits
Pricing
Upfront enrollment fee plus monthly installment plans and long-term storage pricing (20-year or lifetime cryostorage).
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approx. $1.5M-$1.8M in annual revenue (public estimates)
Estimated monthly visits
8K
Traffic estimate as of Oct 2025
Founder Kathryn Cross wrote that she sold Anja Health; the post says service continuity would remain uninterrupted and the team would continue with the buyer.
SourceEIN Presswire · Jun 2026
Anja Health highlighted five years of placenta banking and said it continues to offer cord blood, cord tissue, and placenta preservation through its Vitalant laboratory partnership.
EIN Presswire · Jun 2026
The company expanded its long-running partnership with Vitalant to strengthen processing, cryopreservation, and long-term storage for cord blood, cord tissue, and placenta banking.
EIN Presswire · Jun 2026
Anja Health announced Jan Chen as CEO, citing her 18 years of stem cell banking experience and prior role at FamilyCord; Kathryn Cross said the company was entering a new chapter of growth under Chen's leadership.
Kathryn Cross Substack · May 2026
Founder Kathryn Cross said she sold Anja Health, noted that the service would continue without interruption, and described the company as profitable before the sale.
PR Newswire · May 2022
Anja Health raised a $4.5M seed round led by Seven Seven Six with participation from Harvest Ventures, Crista Galli Ventures, and several angel investors.